Useful Advices
#1 in Business Subscribe Email Print

You are here: Home > Business > Sales Management > The Eight Reasons Why Salespeople Fail

Tags

  • their
  • competent
  • patients
  • biological product
  • biological product
  • biological product

  • Links

  • Is Permanent Laser Hair Removal For You?
  • Luxurious Hotel Accommodation in Perth-Western Australia
  • Green Building: The Time is Now!
  • Useful Advices - The Eight Reasons Why Salespeople Fail

    The responsibility for ensuring that every member of the sales team
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    is successful, lies entirely with management and below are the eig
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    ht reasons why sales people fail.

    In fact, I usually ask just thre
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    e very straightforward questions, in order to identify why a salesp
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    rson is underachieving i.e.

    • Are they visiting/talking to enough
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    clients/prospects?

    • Are they talking to the right people within t
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    hose client/prospect organisations?

    • Are they saying/doing the ri
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    ht things?

    However this list, whilst not exhaustive, remains extre
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    mely accurate and as I said earlier, management has total control o
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    ver each of these, including the last one!!

    • Wrong or no selectio
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    process - The wrong person for the position

    • Wrong or no trainin
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    g - Insufficiently developed

    • Wrong or no planning - Expected to
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    do all of their own planning

    • Wrong or no supervision - Left with
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    out competent supervision

    • Wrong or no motivation - Not properly
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    otivated to meet objectives

    • Wrong or no stimulation - Not stimul
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    ated by appropriate incentives

    • Wrong or no evaluation - Not regu
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    larly appraised against a set of agreed objectives

    • Wrong or no e
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    ecutive action - Not adequately supported by a competent manager

    <
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    b>In Summary:

    These then, are the "Eight Reasons Why Sales Peo
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    ple Fail"

    Copyright © 2006 Jonathan Farrington. All rights reserve


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.usefuladvices.org.ua/article/38615/usefuladvices-The-Eight-Reasons-Why-Salespeople-Fail.html">The Eight Reasons Why Salespeople Fail</a>

    BB link (for phorums):
    [url=http://www.usefuladvices.org.ua/article/38615/usefuladvices-The-Eight-Reasons-Why-Salespeople-Fail.html]The Eight Reasons Why Salespeople Fail[/url]

    Related Articles:

    Laminators Emerge with new Electronic Technology

    Registered Nurse Jobs

    Whats Rong With This Sendtuncts

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com